Publication | Open Access

A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia

Hormonal ContraceptiveFemale ParticipantsMedicineAnabolic SteroidsPlacebo-controlled Clinical TrialHormonal ReceptorGynecologyPharmacotherapyPhase IiaEndocrinologyPharmacologyEndocrine-related CancerWomen's HealthOvarian Cancer